Philips and Qualcomm Announce Strategic Collaboration to Advance Personalized Connected Health Care

PhilipsRoyal Philips (NYSE: PHG; AEX: PHIA) and Qualcomm Incorporated (NASDAQ: QCOM) through its subsidiary, Qualcomm Life, Inc., have announced a strategic technology collaboration to advance connected health across the health continuum - from healthy living and prevention to chronic care management and home care. The companies are teaming up to leverage each other's respective leading capabilities - Philips' leadership in connected health informatics and regulated health care cloud data management and analytics, and Qualcomm Life's expertise in secure, medical-grade device connectivity and integration. This collaboration will enable both companies to offer care providers enhanced, scalable, connected care solutions and services within a secure global ecosystem.

Qualcomm Life’s 2net Platform will serve as the medical device connectivity solution for Philips HealthSuite, the company’s cloud-enabled health ecosystem of devices, apps and digital tools. By joining the Qualcomm Life 2net Ecosystem, Philips provides its HealthSuite users seamless access to a wide array of connected medical devices including medication dispensers, medical grade biosensors, ventilators, blood pressure monitors, point of care self-tests, and blood glucose meters.

Philips will leverage the 2net Platform to connect both Philips and third party medical devices. Secure connectivity, data capture and transmission powered by the 2net Platform, 2net Hub and 2net Mobile, will enable HealthSuite users to customize and scale connected care programs, add additional medical devices and gain a fuller patient profile over longer periods of time, with the aim to support timely intervention, assist in diagnosis, personalize treatment plans and help contribute to the goal of improving patient outcomes. An example of an implementation of this connectivity collaboration will go live shortly with Philips’ Trilogy ventilator family and Care Orchestrator care management application to advance care for patients with COPD and other respiratory conditions.

As part of the collaboration, Qualcomm Life will leverage Philips HealthSuite as a global, secure, data management and storage solution for its medical-grade 2net Platform, allowing Qualcomm Life to tap into the value of health data through data normalization, aggregation and analytics. Qualcomm Life customers can now have direct access to build applications, integrate with electronic health record systems, store normalized data, run analytics, and manage authorization and consents in a compliant and secure environment.

"As the home is fast becoming a viable care setting, care providers, home health agencies, and other institutions are increasingly using connected care to reduce emergency care, readmissions of patients with chronic diseases," said Jeroen Tas, CEO, Connected Care and Health Informatics at Philips. "By collaborating with Qualcomm Life and leveraging its connectivity and wireless expertise, we aim to help care providers to engage better with their patients and contribute to the goal of improving outcomes. Patient self-management combined with 24/7 connectivity to a care network is an emerging model that enables scalable chronic disease management for patients and providers."

"An undeniable leader in the health care technology industry, Philips brings a deep technology expertise to their health care initiatives, and by joining forces we aim to deliver intelligent care to patients and providers at scale," said Rick Valencia, president, Qualcomm Life, Inc. "We are thrilled to be working with Philips, enabling Qualcomm Life to continue to grow its ecosystem and ultimately serve as the underpinning of the Internet of Medical Things."

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company, headquartered in the Netherlands, is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 69,000 employees with sales and services in more than 100 countries.

About Qualcomm Incorporated
Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm's licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm's engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 30 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other..

Qualcomm and 2net are trademarks of Qualcomm Incorporated, registered in the United States and other countries. Other product and brand names may be trademarks or registered trademarks of their respective owners.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...